Drug intelligence / Profile preview

(4-bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone

Development stage: Unknown
Modality: Small Molecules

Overview

This compound, with the chemical name (4-bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone and DrugBank ID DB08458, is a synthetic small molecule. It has not been approved for use in any country and is classified as an experimental drug. There are no known clinical indications or marketed uses for this compound, and it has not advanced beyond preclinical or early research stages. Its mechanism of action, biological targets, therapeutic class, developer(s), and potential indications have not been described in publicly available sources[1][2]. The molecular formula is C21H22BrNO2.

Beyond the preview

Go deeper on (4-bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (4-bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone.

Explore the full profile